R&D Tax Credit — §41
The complete practitioner guide to the Research and Development (R&D) Tax Credit under §41 — covering qualifying research activities, the four-part test, credit calculation methods, and the §174 capitalization rules.
What Qualifies as R&D?
The R&D tax credit under §41 is available for qualifying research activities that meet the four-part test: (1) the research must be undertaken for the purpose of discovering information that is technological in nature; (2) the application of the research must be intended to be useful in the development of a new or improved business component; (3) substantially all of the activities must constitute elements of a process of experimentation; and (4) the research must relate to a new or improved function, performance, reliability, or quality.
| Industry | Common Qualifying Activities |
|---|---|
| Software / Tech | New algorithms, software architecture, AI/ML development |
| Engineering | New structural systems, materials testing, novel designs |
| Architecture | New building systems, sustainable design, novel materials |
| Manufacturing | New manufacturing processes, product improvements, testing |
| Pharmaceuticals | Drug development, clinical trials (pre-FDA approval) |
| Food & Beverage | New recipes, formulations, processing methods |
| Agriculture | New crop varieties, farming techniques, pest control |
Credit Calculation: Regular Method vs. ASC
There are two methods for calculating the R&D credit: the Regular Credit method and the Alternative Simplified Credit (ASC) method. The Regular Credit method is 20% of QREs in excess of the base amount (a fixed-base percentage of gross receipts for the prior 4 years). The ASC method is 14% of QREs in excess of 50% of the average QREs for the three preceding years. The ASC method is simpler to calculate and is used by most taxpayers.
For taxpayers with no QREs in the prior three years (start-up companies), the ASC credit is 6% of current-year QREs. Practitioners should calculate both methods and choose the one that produces the larger credit for the client.
§174 Capitalization: The Key Change
The Tax Cuts and Jobs Act (TCJA) changed the treatment of R&D costs under §174, effective for tax years beginning after December 31, 2021. Prior to 2022, R&D costs could be deducted immediately under §174. Beginning in 2022, domestic R&D costs must be capitalized and amortized over 5 years (15 years for foreign R&D costs). This change significantly increases the taxable income of companies with large R&D expenditures.
The §174 capitalization requirement applies to all R&D costs, including wages, supplies, and contract research. The §41 R&D credit is calculated on the same QREs that are capitalized under §174. The interaction between §174 and §41 is complex, and practitioners should model the impact of the §174 capitalization on the client's tax liability before recommending the R&D credit.
Payroll Tax Offset for Small Businesses
Small businesses (gross receipts under $5 million and no gross receipts for any tax year before the 5-tax-year period ending with the current tax year) can elect to use up to $500,000 of the R&D credit to offset the employer's share of FICA payroll taxes (Social Security tax). This is a significant benefit for start-up companies that have no income tax liability but have significant payroll tax obligations. The payroll tax offset is claimed on the employer's quarterly payroll tax return (Form 941).
Documentation Requirements
The IRS scrutinizes R&D credit claims carefully. Practitioners should advise clients to maintain detailed documentation of qualifying research activities, including: (1) project descriptions explaining the technological uncertainty and process of experimentation; (2) time records showing the hours spent by each employee on qualifying research activities; (3) payroll records showing wages paid to employees for qualifying research activities; (4) records of supplies and contract research expenses; and (5) contemporaneous records created during the research process (lab notebooks, design documents, test results).
Frequently Asked Questions
The four-part test requires: (1) the research must be technological in nature; (2) the application must be intended to be useful in the development of a new or improved business component; (3) substantially all activities must constitute elements of a process of experimentation; and (4) the research must relate to a new or improved function, performance, reliability, or quality.
The Alternative Simplified Credit (ASC) method is 14% of QREs in excess of 50% of the average QREs for the three preceding years. For taxpayers with no QREs in the prior three years, the ASC credit is 6% of current-year QREs.
Beginning in 2022, domestic R&D costs must be capitalized and amortized over 5 years (15 years for foreign R&D costs) under §174. Prior to 2022, R&D costs could be deducted immediately. This change significantly increases the taxable income of companies with large R&D expenditures.
Yes — small businesses (gross receipts under $5 million) can elect to use up to $500,000 of the R&D credit to offset the employer's share of FICA payroll taxes. This is a significant benefit for start-up companies that have no income tax liability.
The R&D credit is available to any industry that conducts qualifying research activities, including software/tech, engineering, architecture, manufacturing, pharmaceuticals, food and beverage, and agriculture.
More Tax Planning FAQs
Ready to Reduce Your Tax Burden?
Our tax advisors specialize in helping professionals and business owners implement these strategies. Book a free strategy call to see how much you could save.
Book A Strategy Call With A Tax AdvisorAccess the Full Practitioner Library
Unlock 200+ tax strategies, IRS form guides, client playbooks, and IRC notice response templates — all at $0/yr.
Explore the Full Library